| Bioactivity | Fotagliptin benzoate is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin benzoate displays great security in rat and dog. Fotagliptin benzoate can be used for Type 2 diabetes mellitus research[1]. |
| In Vivo | Fotagliptin benzoate (33 mg/kg 或 110 mg/kg) 在不同剂量下对大鼠和狗是安全的[1]。 |
| Name | Fotagliptin benzoate |
| CAS | 1403496-40-1 |
| Formula | C24H25FN6O3 |
| Molar Mass | 464.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang Z, et al. Development and validation of a UPLC-MS/MS method for simultaneous determination of fotagliptin and its two major metabolites in human plasma and urine. Bioanalysis. 2017 Feb;9(4):381-393. |
Fotagliptin benzoate
CAS: 1403496-40-1 F: C24H25FN6O3 W: 464.49
Fotagliptin benzoate is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin benzoate displays great
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.